Advanced therapy of inflammatory bowel disease. Volume 1, IBD and ulcerative colitics / Theodore M. Bayless, Stephen B. Hanauer ; editor, Linda Mehta ; cover designer, Mary McKeon.

Format:

Book

Author/Creator:

Bayless, Theodore M., 1931- author.

Hanauer, Stephen B., author.

Contributor:

Mehta, Linda, editor.

McKeon, Mary, cover designer.

Language:

English

Subjects (All):

Inflammatory bowel diseases.

Physical Description:

1 online resource (648 p.)

Edition:

Third edition.

Place of Publication:

Shelton, Connecticut : People's Medical Publishing House, 2011.

Summary:

Now published in two volumes to accommodate new chapters on the many advances in understanding and treatment options, this set of volumes represents the definitive reference on inflammatory bowel disease, a spectrum of diseases that is receiving increasing attention as our understanding of the etiological factors increases and diagnostic tools are refined. Basic research accelerated at the beginning of this decade and is now yielding new, more targeted treatments than were available just a few years ago. Volume 1 is on IBD and Ulcerative Colitis, and Volume 2 is on IBD and Crohn's Disease. All areas that were covered in the 2nd edition have been expanded and updated. New sections include the rapidly expanding knowledge of genetics and the role of the intestinal flora and environmental factors in etiology and pathogenesis. Among the 168 chapters, there are 20 on biologic therapies and 30 on surgical management. The consultant/authors clearly state their approach to important issues, such as the duration of immunomodulator and of anti-TNF-a use and the options for managing isolated low-grade dysplasia. A strong focus on the individual patient is woven throughout both volumes, including the benefits and risks of potentially life-altering therapies and surgeries. Entire sections detail concerns about the well-being of each person. This book provides information for health professionals who help both pediatric and adult patients navigate through the lifelong shadow of a chronic, probably genetically determined ordeal.

Contents:

""Advanced Therapy of IBD: Ulcerative Colitis (Volume 1) ""; ""Contents ""; ""Contributors ""; ""Preface ""; ""Acknowledgments ""; ""Tribute ""; ""Part I: Introduction ""; ""1: Expectations for the Patient with Ulcerative Colitis ""; ""2: Expectations for the Patient with Crohn's Disease ""; ""3: Living with Ulcerative Colitis ""; ""4: Living with Crohn's Disease ""; ""5: Interactions among the Pediatric Patient, His or Her Family, and the Doctor ""; ""6: Dealing with Teens with IBD ""; ""7: Psychosocial Concomitants of Pediatric IBD ""; ""8: Recognizing and Managing Patients Concerns ""

""9: Benefits of Enhancing the Patient-Medical Professional Interface """"Part II: Etiology and Pathophysiology of IBD ""; ""10: IBD Pathogenesis: Current Concepts ""; ""11: IBD Genetics: Potential Clinical Relevance ""; ""12: Effect of Age of Onset on IBD Phenotypes and Genotypes ""; ""13: Environmental Influences in IBD ""; ""14: Biological Therapy in IBD ""; ""15: Addressable Pathophysiologic Alterations in the IBD Patient ""; ""16: Molecular Mechanisms of Colitis-Induced Cancer ""; ""Part III: Diagnostic/Prognostic Methodology ""; ""17: Clinical Subtypes in IBD ""

""18: Computer Database for Patients with IBD """"19: Clinical Measures of Disease Activity ""; ""20: Useful Biological Markers as Activity Indices ""; ""21: The Role of Genetics and Serology in Diagnosing and Predicting the Natural History of IBD ""; ""22: Pediatric IBD: Presentations and Diagnosis, Including Serologies ""; ""23: Clinical Utility of Quallity of Life Measurements ""; ""24: Endoscopy in IBD ""; ""25: Magnifying Colonoscopy in IBD Patients ""; ""26: Endoscopic Biopsies ""; ""27: Crohn's Disease: CT Scanning in Clinical Decision Making ""

""28: CT Enterography and Other Small Bowel Imaging """"29: Imaging IBD with FDG PET and PET/CT ""; ""30: Video Capsule Endoscopy and IBD ""; ""31: Transabdominal Bowel Sonography in Clinical Decision Making ""; ""32: Imaging Options in Perianal Crohn's Disease ""; ""Part IV: Aggravating Factors in IBD ""; ""33: IBD and Stress ""; ""34: ""Refractory"" IBD - A Misnomer? ""; ""35: Infectious Agents as Aggravating Factors in IBD ""; ""36: Viral Infections in IBD ""; ""37: Clostridium difficile and IBD ""; ""38: Nonsteroidal Anti-Inflammatory Drugs and IBD ""; ""39: Smoking and Crohn's Disease ""

""40: Reducing Dietary Symptoms in Irritable Bowel Syndrome and IBD """"41: Coexisting Irritable Bowel Syndrome and IBD ""; ""42: Managing Irritable Bowel Syndrome and IBD in the Same Individual ""; ""43: Adverse Influences of Pregnancy on IBD ""; ""Part V: Medical Therapy of IBD ""; ""44: Pharmacogenomics in IBD ""; ""45: The Placebo Response in IBD ""; ""46: Adherence Issues in the Management of IBD ""; ""47: Emerging Therapeutic Strategies for the Treatment of IBD: Mechanisms & Challenges ""

""48: The Luminal Contents in IBD: What Clinicians Should Know About the Microbiota and its Manipulation ""

Notes:

Description based upon print version of record.

Includes bibliographical references and index at the end of each chapters.

Description based on print version record.

ISBN:

1-60795-216-5

OCLC:

923336891